EPISODE · Sep 15, 2022 · 27 MIN
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
from The Readout Loud · host STAT
Our colleague Katie Palmer joins us to explain a burgeoning trend in pharmaceutical advertising that has health policy experts alarmed. We also discuss the White House's investment in biotech, a bellwether IPO, and the latest twist in the Merck-Seagen saga.
Embed this episode
NOW PLAYING
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
0:00
27:52
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Readout Loud?
This episode is 27 minutes long.
When was this The Readout Loud episode published?
This episode was published on September 15, 2022.
Can I download this The Readout Loud episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!